BridgeMD
Compares treatment options for Stroke
Official title Comparing ESWT Doses for Post-Stroke Ankle Spasticity Treatment
ClinicalTrials.gov ID: NCT05878223
What this study is testing
- What it's testing
- Post-stroke spasticity is a common complication affecting the neurological recovery, self-care daily activities and patients' quality of life. Extracorporeal shock waves (ESWT) have been proven therapeutic effects on decreasing spasticity and regaining function.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 and older
You may be able to join if
- Subject with Cerebral stroke and age more 20
- The degree of spasticity of plantar flexor is more than 1.( grading with the modified Ashworth scale)
- Stable vital sign
You likely can't join if
- Recurrent cerebral stroke, traumatic brain injury, brain tumor or other brain related disease.
- Other central nervous system diseases (SCI, Parkinson's disease), or other musculoskeletal disorders which affect the result of evaluating muscle...
- Malignant tumor, coagulation disorder, infection or use of pace which were not suitable for Extracorporeal Shock Wave.
- Received Extracorporeal Shock Wave or Botulinum injection for plantar flexor spasticity in recent 3 months.
- people who was unable to complete Extracorporeal Shock Wave or evaluation due to impaired cognition or aphasia.
The study team makes the final eligibility decision.
Where it's taking place
- Hsinchu, Taiwan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hsinchu, Taiwan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.